Clinical Trials on Injection Fear in Russian Federation

Total 975 results

Materia Medica Holding

Recruiting

Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

Pneumonia | Community-acquired Pneumonia

Russian Federation
Merck Sharp & Dohme LLC

Completed

Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028)

HIV-1 Infection

United States, Italy, Russian Federation, South Africa, Thailand
Tibotec Pharmaceuticals, Ireland

Completed

A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials

HIV

United Kingdom, Germany, Denmark, Belgium, Austria, Poland, Australia, Russian Federation
Apeiron Biologics

Completed

Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 (APN01-COVID-19)

COVID-19

Denmark, Germany, Austria, Russian Federation, United Kingdom
Bayer

Completed

Comparative Efficacy of Ovule vs Tablet

Vulvovaginal Candidiasis | Clotrimazole | Ovulen

Russian Federation, Germany
GlaxoSmithKline

Terminated

GSK2251052 in the Treatment of Complicated Intra-abdominal Infections

Infections, Intestinal

United States, Czechia, Russian Federation, Spain, Canada, France, Italy
Mannkind Corporation

Completed

Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

Diabetes Mellitus | Upper Respiratory Infection

United States, Russian Federation, Canada
ViiV Healthcare
GlaxoSmithKline

Completed

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

HIV Infections | Infection, Human Immunodeficiency Virus

Mexico, Peru, Thailand, South Africa, Russian Federation, Argentina, Brazil
Materia Medica Holding

Completed

Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia.

Post-acute COVID-19 Syndrome

Russian Federation
Pfizer

Completed

Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).

Complicated Intra-abdominal Infections

Spain, Taiwan, United States, Poland, Hungary, Czechia, Turkey, Greece, Romania, Russian Federation
ViiV Healthcare
GlaxoSmithKline

No longer available

An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc

Infection, Human Immunodeficiency Virus

Belgium, Russian Federation, Italy, South Africa, Argentina, Switzerland, Poland
AstraZeneca

Completed

Aclidinium/Formoterol Fixed Combination Dose Finding Study

Chronic Obstructive Pulmonary Disease (COPD)

Russian Federation, Australia, Czech Republic, Poland
AstraZeneca

Recruiting

Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia (TETRAMER)

Transthyretin Amyloidosis Cardiomyopathy, Heart Failure With Preserved Ejection Fraction

Russian Federation
Gilead Sciences

Active, not recruiting

Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD)

Chronic Hepatitis Delta

Germany, Russian Federation, United States, Italy, Sweden
Novartis Pharmaceuticals

Completed

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years (EARLY)

Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients

Egypt, Greece, Hungary, Russian Federation, Canada, Germany, France, Italy, Switzerland, Romania
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024) (PNEU-PLAN)

Pneumococcal Infections

Finland, Malaysia, Poland, Russian Federation, Thailand
Hospital Universitari Vall d'Hebron Research Institute

Recruiting

Preoperative Oral Antibiotics With vs Without Mechanical Bowel Preparation to Reduce Surgical Site Infections Following Colonic Resection: an International Randomized Controlled Trial. (ORALEV2)

Wounds and Injuries | Surgery--Complications

Spain, Italy, China, Greece, Russian Federation, United Kingdom
Pfizer
PRA Health Sciences

Completed

Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)

Complicated Urinary Tract Infections

United States, Taiwan, Turkey, Czechia, Hungary, Greece, Poland, Romania, Russian Federation
European Society for Blood and Marrow Transplantation

Active, not recruiting

Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation

Central Nervous System Infections | Blood Disease | Infection | Blood Cancer | Central Nervous System Complication | Infectious Disease of Nervous System

Australia, Spain, Italy, Germany, France, Colombia, Hungary, Poland, Russian Federation, Tunisia, Turkey
Javier P. Gisbert

Recruiting

European Registry on the Management of Helicobacter Pylori Infection

H. Pylori Infection

Switzerland, France, Serbia, Latvia, Estonia, Austria, Belgium, Bulgaria, Croatia, Czechia, Denmark, Finland, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovenia and more
Aridis Pharmaceuticals, Inc.

Completed

Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 (AR-301-002)

Staphylococcus Aureus | Pneumonia, Ventilator-Associated | Infection, Bacterial | Lung Infection

Belarus, Belgium, Brazil, China, Estonia, France, Georgia, Israel, Latvia, Mexico, Russian Federation, South Africa, Spain, Turkey, Ukraine
Janssen Infectious Diseases BVBA

Completed

TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).

Tuberculosis

South Africa, Peru, Latvia, Philippines, Russian Federation, Thailand, Brazil, India
Pfizer

Completed

Real-World Observational Study Of Zavicefta to Characterize Use Patterns (EZTEAM)

Infection

France, United Kingdom, Spain, Colombia, Argentina, Germany, Italy, Austria, Russian Federation, Brazil, Greece
Dermax SA
bioRASI, LLC

Completed

Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts

External Anogenital Warts

Russian Federation, United States, Ukraine
Materia Medica Holding

Completed

Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI

Preventive Medicine

Russian Federation, Uzbekistan
Pfizer
Allergan

Terminated

Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria

Serious Bacterial Infection

Romania, Taiwan, China, Malaysia, Thailand, Philippines, Argentina, Greece, India, United States, Mexico, Russian Federation
Masaryk University

Recruiting

COVID-19 Vaccines Safety Tracking (CoVaST)

Adverse Reaction to Vaccine | COVID19 Vaccine

Poland, Canada, United States, Croatia, Czechia, Estonia, Ethiopia, Germany, Ghana, Mexico, Portugal, Russian Federation, Serbia, Slovenia
Pfizer

Completed

A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections

Acute Otitis Media

United States, Costa Rica, Chile, Guatemala, Slovakia, Estonia, Mexico, Russian Federation, Israel, Poland, Argentina, Dominican Republic, Panama
UCB Pharma

Terminated

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)

Rheumatoid Arthritis | Crohn's Disease

Russian Federation
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects (ING112276)

Infection, Human Immunodeficiency Virus

United States, Spain, France, Germany, Italy, Russian Federation
Pfizer
Forest Laboratories

Completed

Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens

Complicated Intra-abdominal Infection | Complicated Urinary Tract Infection

Croatia, Bulgaria, Korea, Republic of, Mexico, Peru, Russian Federation, Spain, Turkey, Poland, Romania, Ukraine, South Africa, Argentina, Israel, United States, Philippines, France, Czechia
Sanofi
Regeneron Pharmaceuticals

Completed

Sarilumab COVID-19

Corona Virus Infection

Italy, Japan, Israel, Argentina, Russian Federation, Germany, Spain, Brazil, Chile, Canada, France
Università Vita-Salute San Raffaele

Recruiting

Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients. (ANH)

C.Surgical Procedure; Cardiac

Singapore, Saudi Arabia, Italy, Russian Federation, Serbia, Thailand
Gilead Sciences

Completed

Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults

HIV Infections | Acquired Immunodeficiency Syndrome | HIV

United States, Thailand, Uganda, Dominican Republic, Russian Federation
Forest Laboratories

Completed

Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections

Urinary Tract Infections

Russian Federation, Bulgaria, Poland, Germany, United States, Lebanon, Turkey
Forest Laboratories
AstraZeneca

Completed

Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus

Infections

Poland, Romania, Russian Federation, Ukraine, Georgia, Hungary, United States, Spain
GlaxoSmithKline

Terminated

GSK2251052 in Complicated Urinary Tract Infection

Infections, Urinary Tract

France, United States, Russian Federation, Spain, Greece, Canada
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection

Hepatitis C Virus Infection

United States, Italy, United Kingdom, Germany, Belgium, Russian Federation, New Zealand, Australia
Bristol-Myers Squibb

Completed

A Phase 3 Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection

Hepatitis C

China, Korea, Republic of, Russian Federation
Bayer

Completed

Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection (MOXIPEDIA)

Intraabdominal Infections

Greece, Peru, United States, Chile, Bulgaria, Canada, Russian Federation, Lithuania, Germany, Hungary, Latvia, Romania, Ukraine, Czechia, Argentina, Mexico
Pfizer

Completed

Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT) (IMPROVIT)

Antifungal Prophylaxis of Invasive Fungal Infections

Canada, Spain, Greece, France, Portugal, United Kingdom, Czech Republic, Egypt, Jordan, Russian Federation, Switzerland, Turkey
ViiV Healthcare
GlaxoSmithKline

Completed

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

Infection, Human Immunodeficiency Virus I

United States, Spain, Canada, Russian Federation, Romania, Belgium, South Africa
Sanofi

Completed

Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide (TERIVA)

Multiple Sclerosis

Germany, Ukraine, Canada, Austria, Russian Federation
Pfizer
Forest Laboratories

Completed

Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections

Complicated Intra-Abdominal Infection

United States, Croatia, Bulgaria, Peru, Russian Federation, Latvia, Ukraine, Mexico, Romania, South Africa, Argentina, Czechia, Hungary, Israel, Taiwan, India, Thailand, Spain, Netherlands, Malaysia
Novartis Pharmaceuticals

Completed

Second Open Label Extension to Bridging Study CTBM100C2303

Pseudomonas Aeruginosa | Pulmonary Infections

Russian Federation, Romania, Estonia, Latvia, Lithuania, Bulgaria, South Africa
Allecra
Medpace, Inc.

Completed

Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections

Urinary Tract Infections

United States, Serbia, Hungary, Estonia, South Africa, Belarus, Poland, Ukraine, Argentina, Bulgaria, Croatia, Georgia, Latvia, Lithuania, Mexico, Peru, Russian Federation, Slovakia, Spain
SPP Pharmaclon Ltd.

Recruiting

A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis

Respiratory Tuberculosis

Russian Federation
Merck Sharp & Dohme LLC

Recruiting

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection

United States, Mexico, Russian Federation, South Africa, Thailand
Lumara Health, Inc.

Completed

Vaginal Infection Study 2

Vaginal Infection

United States, Russian Federation, India
Melinta Therapeutics, Inc.

Completed

Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Skin and Subcutaneous Tissue Bacterial Infections

United States, Croatia, Israel, Latvia, Russian Federation, Spain, Ukraine

Clinical Trials on Injection Fear in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations